Media release

DKSH to Distribute SINOVAC CoronaVac in Hong Kong

DKSH to Distribute SINOVAC CoronaVac in Hong Kong

DKSH Hong Kong has been granted the provision of import, storage, delivery and logistic support services to the Department of Health for SINOVAC CoronaVac COVID-19 vaccine in Hong Kong.

Hong Kong, August 30, 2022 – DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business in Asia and beyond, is pleased to announce DKSH Hong Kong has been granted the provision of import, storage, delivery and logistic support services to the Department of Health (DoH) of the Hong Kong Special Administrative Region Government for SINOVAC CoronaVac COVID-19 vaccine in Hong Kong.

SINOVAC CoronaVac has been one of the two key COVID-19 vaccines adopted by Hong Kong since the pandemic outbreak.

In conjunction with the core logistic capabilities, DKSH offers service assurance in four key areas: quality and compliance, reliable cold-chain capability, supply chain coverage, and secured distribution. Dedicated project teams and truck fleet will be deployed to support the distribution of CoronaVac.

DKSH cold chain facility manages various life-saving drugs and healthcare products, including SINOVAC’s CoronaVac, with the required temperature specifications. To further facilitate the vaccine’s storage and delivery demand for both routine and emergencies, DKSH’s team of experts set up contingency plans and temperature control measures to ensure zero excursion under different circumstances.

In addressing the need for flexible distribution and extensive coverage of the vaccine to different vaccination centers, hospitals, and clinics, DKSH has designed designated logistic processes, fleet route map and facilitation plans to safeguard a sustainable supply of vaccines.

During an engagement session at DKSH Mapletree Distribution Center to welcome the official move-in of SINOVAC CoronaVac, Ms Cheryl Law, International Business Development Director of SINOVAC, said: “We send our congratulations to DKSH for winning the tender. We are impressed with the operation and automation of this DC facility and strongly believe DKSH has the capability to support in combating the pandemic.”

Fong Wai Ting, Head of Management and Vice President, Healthcare, DKSH Hong Kong & Macau, commented: “This is a significant milestone for DKSH. We are honored to serve Hong Kong’s citizens by supporting the distribution of SINOVAC CoronaVac. This project echoes DKSH’s mission of enriching people’s lives and is a strong recognition of the company’s proven capability in the cold chain management, extensive industry network, and uncompromising pursuit of quality. I would also like to take this opportunity to acknowledge our team’s effort to make this project happen.”